Gene symbol | RPGR | Synonyms | COD1, CORDX1, CRD, PCDX, RP15, RP3, XLRP3, orf15 | Type of gene | protein-coding |
Chromosome | X | Map location | Xp11.4 | dbXrefs | |
Description | retinitis pigmentosa GTPase regulator |
GTO ID | GTC2619 |
Trial ID | NCT04794101 |
Disease | Retinitis Pigmentosa |
Altered gene | RPGR |
Therapeutic/Target gene | Therapeutic gene |
Therapy | Gene transfer |
Treatment | botaretigene sparoparvovec |
Phase | Phase3 |
Recruitment status | Recruiting |
Title | Follow-up Phase 3 Randomized, Controlled Study of AAV5-RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene |
Year | 2020 |
Country | Belgium|Canada|Denmark|France|Israel|Italy|Netherlands|Spain|Switzerland|United Kingdom|United States |
Company sponsor | MeiraGTx UK II Ltd |
Other ID(s) | MGT-RPGR-022|2020-002255-37 |
Vector information | |||||||||||
|
Cohort1: dose level 1 | |||||||||
|
|||||||||
Cohort2: dose level 2 | |||||||||
|